The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma
Saved in:
| Main Authors: | D. Zakria, J. Burshtein, M. Shah, J. Siegel, S. Morgan-Linnell, B. Martin, R. Cook |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824000971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma
by: J. Michael Guenther, et al.
Published: (2025-01-01) -
CD31 and CD34 Expression as Immunohistochemical Markers of Endothelial Transdifferentiation in Human Cutaneous Melanoma
by: A. M. Pisacane, et al.
Published: (2007-01-01) -
Ultrasound scan in planning surgery for cutaneous melanoma of the extremities
by: N. A. Maksimova, et al.
Published: (2019-02-01) -
Systematic Automated Population-Based Surveillance to Improve Outcomes in Primary Cutaneous Melanoma
by: Allison Ching, et al.
Published: (2024-12-01) -
The features of leptin and its receptor expression in metastatic cutaneous melanoma
by: A. A. Lushnikova, et al.
Published: (2015-06-01)